You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
樂普醫療(300003.SZ):子公司心泰醫療今日正式登陸港交所

格隆匯11月8日丨樂普醫療(300003.SZ)公吿稱,公司控股子公司樂普心泰醫療科技(上海)股份有限公司(簡稱“心泰醫療”)於2021年11月11日獲得中國證監會《關於核准樂普心泰醫療科技(上海)股份有限公司發行境外上市外資股及境內未上市股份到境外上市的批覆》(證監許可[2021]3600號)。2022年11月7日香港聯交所批准心泰醫療H股股份在香港聯交所主板上市及交易。

全球發售完成後,心泰醫療於2022年11月8日在香港聯交所主板上市,心泰醫療H股股份於2022年11月8日上午九時開始在香港聯交所主板交易,心泰醫療股份代號為02291。在全球發售完成後且假設超額配股權未獲行使,公司直接及間接合計持有2.8億股心泰醫療股份,佔心泰醫療已發行股本總額約80.75%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account